Differential Detection of Tumor Cells Using a Combination of Cell Rolling, Multivalent Binding, and Multiple Antibodies
暂无分享,去创建一个
[1] Daniel F. Hayes,et al. Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets , 2013, Nature nanotechnology.
[2] Hongtao Feng,et al. High throughput capture of circulating tumor cells using an integrated microfluidic system. , 2013, Biosensors & bioelectronics.
[3] Xiaohong Fang,et al. High‐Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber‐Embedded Microchip for Whole Exome Sequencing , 2013, Advanced materials.
[4] Xiaochun Xu,et al. Specific Capture and Release of Circulating Tumor Cells Using Aptamer‐Modified Nanosubstrates , 2013, Advanced materials.
[5] H. Tseng,et al. Capture and Stimulated Release of Circulating Tumor Cells on Polymer‐Grafted Silicon Nanostructures , 2013, Advanced materials.
[6] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[7] Seungpyo Hong,et al. The role of polymers in detection and isolation of circulating tumor cells , 2012 .
[8] Boran Cheng,et al. Electrospun TiO2 Nanofiber‐Based Cell Capture Assay for Detecting Circulating Tumor Cells from Colorectal and Gastric Cancer Patients , 2012, Advanced materials.
[9] I. Tinhofer,et al. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.
[10] Sridhar Ramaswamy,et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.
[11] Keiichiro Sakuma,et al. Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial–mesenchymal transition , 2012, Proceedings of the National Academy of Sciences.
[12] David T. Eddington,et al. Channel surface patterning of alternating biomimetic protein combinations for enhanced microfluidic tumor cell isolation. , 2012, Analytical chemistry.
[13] Seungpyo Hong,et al. Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. , 2011, Angewandte Chemie.
[14] Anil K Sood,et al. A novel platform for detection of CK+ and CK- CTCs. , 2011, Cancer discovery.
[15] Susana Campuzano,et al. Micromachine-enabled capture and isolation of cancer cells in complex media. , 2011, Angewandte Chemie.
[16] Seungpyo Hong,et al. Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin. , 2011, Analytical chemistry.
[17] K. Isselbacher,et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.
[18] Benjamin Thierry,et al. Herceptin functionalized microfluidic polydimethylsiloxane devices for the capture of human epidermal growth factor receptor 2 positive circulating breast cancer cells. , 2010, Biomicrofluidics.
[19] L. Borsig,et al. Selectins promote tumor metastasis. , 2010, Seminars in cancer biology.
[20] Seungpyo Hong,et al. Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs). , 2010, Langmuir : the ACS journal of surfaces and colloids.
[21] Michael R. King,et al. Biomolecular Surfaces for the Capture and Reprogramming of Circulating Tumor Cells , 2009 .
[22] D. Dearnaley,et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. , 2009, Cancer research.
[23] M. Brosnan,et al. Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity , 2009, Breast Cancer Research.
[24] Mieke Schutte,et al. Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells , 2009, Journal of the National Cancer Institute.
[25] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[26] D. Krag,et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.
[27] Mehmet Toner,et al. Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.
[28] G. Kallergi,et al. Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer , 2008, Clinical Cancer Research.
[29] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[30] G. T. Budd,et al. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.
[31] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[32] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[33] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[34] Y. Hannun,et al. EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy , 2004, Cancer Research.
[35] M. Weinstein,et al. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] J. Manola,et al. Her-2-neu expression and progression toward androgen independence in human prostate cancer. , 2000, Journal of the National Cancer Institute.
[37] B. Tombal,et al. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. , 1998, Clinical chemistry.
[38] P. Möller,et al. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.
[39] Klaus Pantel,et al. Circulating tumor cells: liquid biopsy of cancer. , 2013, Clinical chemistry.